date:Dec 13, 2012
On October 9 2012, the group announced its intention to divest the pharmaceutical ingredients activities Calaire and Farchemia. Information and consultation procedures were completed early November.
After clearance by the merger control authorities , the sale was completed on December 5 2012. This divestment is in line with Tessenderlo Groups strengthened focus on specialty products and services in the areas of food, agriculture, water management and valorizing bio-residuals. Calaire and Farch